reference/30227283

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30227283

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1263
issn	0140-6736
issueIdentifier	9671
pageRange	1253-1263
publicationName	Lancet (London, England)
startingPage	1253
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_51e75ae2177a3fe8931d3e8126b37886
bibliographicCitation	Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN; HORIZON investigators. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2009 Apr 11;373(9671):1253–63. doi: 10.1016/s0140-6736(09)60250-6. PMID: 19362675.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d06530fccc5bfd39001c9b5a1a22c83e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35810820b2d4a5b6b21ec2dd6501f254 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0bc2a9f8bfe17ee338e677838ec7f9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0076123707f8cc0798bbfc88243d560e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9a708c00ee2e9683fc2c09973e590e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4d55a2779940630b50d082993bba0b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a94a7790a0445a78667bed5b408a139 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f52a98d5d9f062513a0c5b2a87463a92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42be3dce8c2b98cf9c28315746401976 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f56d0c7df7e22182f4301bdc8eb4180c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_124fd6b13750eed0ff35eb06989de460 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf703680ae5e4e2024732d19a0f5545a
date	2009-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/s0140-6736%2809%2960250-6 https://pubmed.ncbi.nlm.nih.gov/19362675
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470 https://portal.issn.org/resource/ISSN/0140-6736
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0009322 http://id.nlm.nih.gov/mesh/M0472480 http://id.nlm.nih.gov/mesh/M0020098 http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0006519 http://id.nlm.nih.gov/mesh/M000603388 http://id.nlm.nih.gov/mesh/M0011048
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010024Q000188 http://id.nlm.nih.gov/mesh/D012968Q000031 http://id.nlm.nih.gov/mesh/D010024Q000139 http://id.nlm.nih.gov/mesh/D050071Q000627 http://id.nlm.nih.gov/mesh/D005938Q000009 http://id.nlm.nih.gov/mesh/D007093Q000627 http://id.nlm.nih.gov/mesh/D004164Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D000077211 http://id.nlm.nih.gov/mesh/D012968Q000627 http://id.nlm.nih.gov/mesh/D007093Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012968Q000009 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D016018 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D015519Q000187 http://id.nlm.nih.gov/mesh/D000068296 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D000704 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D004164Q000009 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5245 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128171553 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127711966

Total number of triples: 77.